Literature DB >> 27759598

Incidental Findings in Abdominal Dual-Energy Computed Tomography: Correlation Between True Noncontrast and Virtual Noncontrast Images Considering Renal and Liver Cysts and Adrenal Masses.

Karin Slebocki1, Bastian Kraus, De-Hua Chang, Martin Hellmich, David Maintz, Christopher Bangard.   

Abstract

PURPOSE: To assess correlation between attenuation measurements of incidental findings in abdominal second generation dual-energy computed tomography (CT) on true noncontrast (TNC) and virtual noncontrast (VNC) images.
MATERIALS AND METHODS: Sixty-three patients underwent arterial dual-energy CT (Somatom Definition Flash, Siemens; pitch factor, 0.75-1.0; gantry rotation time, 0.28 seconds) after endovascular aneurysm repair, consisting of a TNC single energy CT scan (collimation, 128 × 0.6 mm; 120 kVp) and a dual-energy arterial phase scan (collimation, 32 × 0.6 mm, 140 and 100 kVp; blended, 120 kVp data set). Attenuation measurements in Hounsfield units (HU) of liver parenchyma and incidental findings like renal and hepatic cysts and adrenal masses on TNC and VNC images were done by drawing regions of interest. Statistical analysis was performed by paired t test and Pearson correlation.
RESULTS: Incidental findings were detected in 56 (89%) patients. There was excellent correlation for both renal (n = 40) and hepatic cysts (n = 12) as well as adrenal masses (n = 6) with a Pearson correlation of 0.896, 0.800, and 0.945, respectively, and mean attenuation values on TNC and VNC images of 10.6 HU ± 12.8 versus 5.1 HU ± 17.5 (attenuation value range from -8.8 to 59.1 HU vs -11.8 to 73.4 HU), 6.4 HU ± 5.8 versus 6.3 HU ± 4.6 (attenuation value range from 2.0 to 16.2 HU vs -3.0 to 15.9 HU), and 12.8 HU ± 11.2 versus 12.4 HU ± 10.2 (attenuation value range from -2.3 to 27.5 HU vs -2.2 to 23.6 HU), respectively. As proof of principle, liver parenchyma measurements also showed excellent correlation between TNC and VNC (n = 40) images with a Pearson correlation of 0.839 and mean attenuation values on TNC and VNC images of 47.2 HU ± 10.5 versus 43.8 HU ± 8.7 (attenuation value range from 21.9 to 60.2 HU vs 4.5 to 65.3 HU).
CONCLUSIONS: In conclusion, attenuation measurements of incidental findings like renal cysts or adrenal masses on TNC and VNC images derived from second generation dual-energy CT scans show excellent correlation providing considerable dose savings, favorable for future application in clinical routine.

Entities:  

Mesh:

Year:  2017        PMID: 27759598     DOI: 10.1097/RCT.0000000000000503

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  6 in total

Review 1.  Use of dual-energy CT for renal mass assessment.

Authors:  Shanigarn Thiravit; Christina Brunnquell; Larry M Cai; Mena Flemon; Achille Mileto
Journal:  Eur Radiol       Date:  2020-11-18       Impact factor: 5.315

2.  Dual-energy CT arthrography: a feasibility study.

Authors:  Rashpal Sandhu; Mercan Aslan; Nancy Obuchowski; Andrew Primak; Wadih Karim; Naveen Subhas
Journal:  Skeletal Radiol       Date:  2020-09-18       Impact factor: 2.199

Review 3.  Quantitative dual-energy CT techniques in the abdomen.

Authors:  Giuseppe V Toia; Achille Mileto; Carolyn L Wang; Dushyant V Sahani
Journal:  Abdom Radiol (NY)       Date:  2021-09-01

Review 4.  Spectral detector CT applications in advanced liver imaging.

Authors:  Noor Fatima Majeed; Marta Braschi Amirfarzan; Christoph Wald; Jeremy R Wortman
Journal:  Br J Radiol       Date:  2021-05-28       Impact factor: 3.629

5.  Initial clinical radiological findings and staging to predict prognosis of primary hepatic angiosarcoma: A retrospective analysis.

Authors:  Wei-Hsin Yuan; Anna Fen-Yau Li; Hui-Chen Hsu; Yong-Sin Hu; Rheun-Chuan Lee
Journal:  PLoS One       Date:  2019-11-11       Impact factor: 3.240

6.  Quantitative accuracy of virtual non-contrast images derived from spectral detector computed tomography: an abdominal phantom study.

Authors:  Jasmin A Holz; Hatem Alkadhi; Kai R Laukamp; Simon Lennartz; Carola Heneweer; Michael Püsken; Thorsten Persigehl; David Maintz; Nils Große Hokamp
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.